​

Axsome Therapeutics Ownership | Who Owns Axsome Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Axsome Therapeutics Ownership Summary

Axsome Therapeutics is owned by 75.17% institutional investors, 15.08% insiders, and 9.75% retail investors. Vanguard group is the largest institutional shareholder, holding 8.33% of AXSM shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 2.74% of its assets in Axsome Therapeutics shares.

AXSM Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAxsome Therapeutics75.17%15.08%9.75%
SectorHealthcare Stocks 50.59%12.40%37.01%
IndustryBiotech Stocks 49.10%12.14%38.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group4.16M8.33%$760.66M
Blackrock3.30M6.96%$265.65M
Blackrock funding, inc. /de3.10M6.06%$759.69M
Vanguard capital management1.97M3.84%$480.99M
Invesco1.67M3.27%$409.18M
Fmr1.54M3.01%$376.74M
Geode capital management967.17K1.89%$236.79M
Fairmount funds management815.18K1.65%$99.00M
Morgan stanley804.08K1.57%$196.82M
State street785.66K1.53%$192.29M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Alethea capital management648.76K65.78%$158.80M
Svb capital management33.85K12.95%$4.11M
Fairmount funds management815.18K8.91%$99.00M
Superstring capital management lp53.92K8.33%$13.20M
Tri locum partners lp219.31K6.60%$53.68M
First turn management218.41K5.72%$53.46M
Panoramic capital44.00K4.63%$10.77M
Pfm health sciences, lp219.60K4.61%$53.75M
Iridian asset management llc/ct47.92K4.03%$11.73M
Ghost tree capital150.00K3.78%$12.07M

Top Buyers

HolderShares% AssetsChange
Millennium management556.09K0.05%535.33K
Norges bank514.27K0.01%514.27K
Jane street group404.00K0.01%399.92K
Invesco1.67M0.03%374.01K
Two sigma investments, lp669.48K0.12%346.70K

Top Sellers

HolderShares% AssetsChange
Ra capital management---1.00M
Rtw investments, lp---888.00K
Blackrock funding, inc. /de3.10M0.01%-809.14K
Price t rowe associates inc /md/642.89K0.02%-674.17K
Wellington management group llp653.92K0.03%-491.39K

New Positions

HolderShares% AssetsChangeValue
Norges bank514.27K0.01%514.27K$125.88M
Sixth street partners management company316.10K0.01%316.10K$77.37M
Samlyn capital246.01K0.98%246.01K$60.22M
Westfield capital management co lp145.15K0.12%145.15K$35.53M
Arrowstreet capital, limited partnership135.19K0.01%135.19K$33.09M

Sold Out

HolderChange
Dunhill financial-1.00
Atlantic union bankshares-1.00
Financial gravity asset management-1.00
Geowealth management-5.00
Montag a & associates-8.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202653323.67%38,485,1631.51%751.29%29637.04%16111.03%
Mar 31, 20264220.24%37,198,853-1.17%741.32%211-6.64%14215.45%
Dec 31, 2025127-66.49%7,628,642-79.48%150.27%58-71.14%38-60.42%
Sep 30, 2025146-59.22%7,876,625-78.56%150.29%77-62.44%34-60.47%
Jun 30, 2025365-3.18%37,827,2692.24%761.33%2069.57%89-25.21%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard MStar Total Stk Mkt Idx Invest1.39M2.74%4.40K
Vanguard Total Stock Mkt Idx Inv1.39M2.70%2.81K
Vanguard Morn Total Stk Mkt Idx Investor1.39M2.70%2.81K
Vanguard US Total Market Shares ETF1.31M2.69%114.89K
Vanguard Small Cap Index1.00M1.98%1.85K
iShares Russell 2000 ETF990.97K1.93%9.15K
Macquarie Small Cap Core I651.89K1.31%-48.97K
Delaware Small Cap Core I579.64K1.21%-3.59K
Vanguard MStar Small Cap Growth Indx Inv581.83K1.14%2.53K
Vanguard Small Cap Growth Index Inv579.30K1.13%16.16K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 05, 2026TABUTEAU HERRIOT Chief Executive OfficerSell$9.54M
Aug 06, 2026TABUTEAU HERRIOT Chief Executive OfficerSell$997.01K
Jul 01, 2026TABUTEAU HERRIOT Chief Executive OfficerSell$11.93M
Jun 11, 2026JEFFS ROGER-Sell$71.25K
Jun 10, 2026JEFFS ROGER-Sell$70.41K

Insider Transactions Trends

DateBuySell
2026 Q3-3
2026 Q2-13
2026 Q1-8
2025 Q4-10
2025 Q3313

AXSM Ownership FAQ

Who Owns Axsome Therapeutics?

Axsome Therapeutics shareholders are primarily institutional investors at 75.17%, followed by 15.08% insiders and 9.75% retail investors. The average institutional ownership in Axsome Therapeutics's industry, Biotech Stocks , is 49.10%, which Axsome Therapeutics exceeds.

Who owns the most shares of Axsome Therapeutics?

Axsome Therapeutics’s largest shareholders are Vanguard group (4.16M shares, 8.33%), Blackrock (3.3M shares, 6.96%), and Blackrock funding, inc. /de (3.1M shares, 6.06%). Together, they hold 21.35% of Axsome Therapeutics’s total shares outstanding.

Does Blackrock own Axsome Therapeutics?

Yes, BlackRock owns 6.96% of Axsome Therapeutics, totaling 3.3M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 265.65M$. In the last quarter, BlackRock increased its holdings by 104.5K shares, a 3.27% change.

Who is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested?

Alethea capital management is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested, with 65.78% of its assets in 648.76K Axsome Therapeutics shares, valued at 158.8M$.

Who is the top mutual fund holder of Axsome Therapeutics shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of Axsome Therapeutics shares, with 2.74% of its total shares outstanding invested in 1.39M Axsome Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools